Development and Validation of an RP-HPLC Analytical Method for Oxycodone in Pharmaceutical Dosage Forms
Keywords:Oxycodone, validation, HPLC, precision, LOD & LOQ, stability
This research focuses on development and validation of HPLC analysis of oxycodone in pharmaceutical dosage form. A mixture of methanol:acetonitrile:water (40:40:20% v/v) at pH 4.0 was identified as the optimal choice The established technique has been validated in accordance with ICH accepted standards. Linearity and range assessments established a linear range of 50–150 µg/ml with a high correlation coefficient of 0.997. Accuracy was confirmed through recovery studies, with recoveries ranging from 97.04% to 100.83% for oxycodone. Precision was evaluated through repeatability, intra-day, and inter-day precision studies, demonstrating low relative standard deviation (RSD) values Detection sensitivity was determined by the limits of detection (LOD) and quantification (LOQ), which were found to be 0.99 µg/ml and 3.01 µg/ml, respectively. The stability of standard and sample solutions was examined at room temperature for 48 hours, with a relative standard deviation below 2.0%. The determination of oxycodone in pharmaceutical dosage forms was made possible by the present validated technique, which has exceptional specificity, linearity, precision, sensitivity, and reliability
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.